NEW ORLEANS (Legal Newsline) – Louisiana Attorney General James “Buddy” Caldwell has filed a lawsuit in state court against the maker of the prescription nasal spray Flonase for allegedly scheming to ...

A federal judge has certified a class action antitrust suit against pharmaceuticals giant GlaxoSmithKline that accuses the company of using a series of illegal tactics to delay the approval of generic ...

GlaxoSmithKline said Friday it got a temporary restraining order blocking the shipment and sales of a recently FDA-approved generic competitor to its Flonase nasal spray. The order applies to Roxane ...

NEW ORLEANS (Legal Newsline) – Pharmaceutical giant GlaxoSmithKline is attempting to have an antitrust lawsuit filed by the Louisiana Attorney General’s Office last December thrown out claiming it is ...

GlaxoSmithKline PLC will pay $6 million to resolve a lawsuit by Louisiana alleging it illegally tried to delay generic versions of its allergy spray Flonase, ending the drugmaker's appeal to the U.S.

WARREN, N.J., May 3, 2021 /PRNewswire/ -- GSK Consumer Healthcare (LSE/NYSE: GSK), the makers of Voltaren Arthritis Pain Gel (diclofenac sodium topical gel, 1%) today revealed new data that uncovers..

At an update to investors, GlaxoSmithKline announced that the proposed listing of Haleon — the newly independent company to be formed following the demerger of the GSK Consumer Healthcare business — ...

WASHINGTON (AP) _ Generic versions of the popular Flonase nasal spray for allergies are headed to pharmacies after all. Generic makers Roxane Laboratories and Par Pharmaceuticals announced Tuesday ...